Executive Summary
From Lab to Launch: Successful Drug Development Strategies Using Lipid-Based Formulations and Softgels
Summary: Softgels are ideal for LBF delivery and are compatible with various formulations. Innovations like delayed release and plant-based capsules enhance drug delivery. LBFs with a Quality-by-Design approach offer an efficient route to market for complex drugs.
View Now
Article
Nasal Powder: A Stable, Rapid-Onset Strategy for Systemic Therapy
Summary: Originally published in Inhalation magazine, this article discusses how nasal powder formulations represent a significant stride in drug delivery innovation. With drug developers and approvers evolving to address the unique considerations of nasal drug delivery, nasal powders offer a robust and adaptable platform in the pharmaceutical landscape.
View Now
Webinars
Webinar: CDMOs’ Critical Role in a Rapidly Evolving Biopharma Landscape
Summary: ×îÐÂÉ«ÇéӰƬ President and CEO Alessandro Maselli sits down with Endpoints News founder John Carroll to discuss the evolving role of CDMOs and what’s next for ×îÐÂÉ«ÇéӰƬ as it progresses with its shift from public to private ownership under its previously announced transaction with Novo Holdings.
View Now
Article
Harnessing Softgels for Patient-Centric Drug Delivery
Learn how softgel capsules have advanced drug delivery by encapsulating a variety of active pharmaceutical ingredients (APIs).
View Now
Video
Integrated approach to Lipid-Based Formulations (LBF)
Summary: In this interview with Pharmtech, Karunakar Sukuru, Global Vice President, Rx Product Development, Pharma and Consumer Health, ×îÐÂÉ«ÇéӰƬ shares his thoughts on the key benefits of Lipid based formulations (LBF.)
View Now
Executive Summary
Integrated Clinical Development & Supply: Breaking Down the Early Development Journey of a Small Molecule
Summary: This executive summary showcases examples of real-life tactical and operational decisions involved in the integrated approach to drug development.
View Now
Webinars
Enabling Adaptive Clinical Trials through Integrated Development and Manufacturing Solutions
Summary: In this webinar, industry experts will discuss how a manufacturing on-demand strategy can enhance your clinical development and improve drug supply utilization.
View Now
Article
ARCUS®: A Commercialized Technology Enabling High-Dose, Highly Respirable Powders
Summary: In this article, Dr. Alan Watts, Director of Innovation & Partnerships for Orally Inhaled Products at ×îÐÂÉ«ÇéӰƬ, and Michael Tauber, Senior Director of Pharmaceutical Development at Acorda Therapeutics discuss the requirements and benefits of using spray-dried powders for inhalation, and how ARCUS can be used to successfully bring new inhaled therapies to market.
View Now
Article
Your Perfect Partner for Dry Powder Inhalation
Summary: This article discusses how to successfully develop and manufacture spray-dried pulmonary and nasal powders and how a CDMO partner plays an integral role in the successful development and commercialization of inhalation products.
View Now
Offering Fact Sheet
Nitrosamine Testing Services
Summary: Download this fact sheet to learn more about our experience and expertise with nitrosamines testing.
View Now